BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fleury Curado T, Pho H, Freire C, Amorim MR, Bonaventura J, Kim LJ, Lee R, Cabassa ME, Streeter SR, Branco LG, Sennes LU, Fishbein K, Spencer RG, Schwartz AR, Brennick MJ, Michaelides M, Fuller DD, Polotsky VY. Designer Receptors Exclusively Activated by Designer Drugs Approach to Treatment of Sleep-disordered Breathing. Am J Respir Crit Care Med 2021;203:102-10. [PMID: 32673075 DOI: 10.1164/rccm.202002-0321OC] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Martins MG, Magliarelli Filho PA, Nagahashi Marie SK, Sennes LU. Distribution of leptin receptors in the brain stem: possible route in the pathophysiology of neuromuscular control of airway resistance during sleep. Sleep Medicine 2022. [DOI: 10.1016/j.sleep.2022.03.017] [Reference Citation Analysis]
2 Amorim MR, Dergacheva O, Fleury-Curado T, Pho H, Freire C, Mendelowitz D, Branco LGS, Polotsky VY. The Effect of DREADD Activation of Leptin Receptor Positive Neurons in the Nucleus of the Solitary Tract on Sleep Disordered Breathing. Int J Mol Sci 2021;22:6742. [PMID: 34201760 DOI: 10.3390/ijms22136742] [Reference Citation Analysis]
3 Song J, Patel RV, Sharif M, Ashokan A, Michaelides M. Chemogenetics as a neuromodulatory approach to treating neuropsychiatric diseases and disorders. Mol Ther 2021:S1525-0016(21)00636-5. [PMID: 34861415 DOI: 10.1016/j.ymthe.2021.11.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Perger E, Taranto-Montemurro L. Upper airway muscles: influence on obstructive sleep apnoea pathophysiology and pharmacological and technical treatment options. Curr Opin Pulm Med 2021;27:505-13. [PMID: 34431788 DOI: 10.1097/MCP.0000000000000818] [Reference Citation Analysis]
5 Veasey S. An X on the Map for Sleep Apnea's Holy Grail: Drug Therapy. Am J Respir Crit Care Med 2021;203:10-1. [PMID: 32750248 DOI: 10.1164/rccm.202007-2785ED] [Reference Citation Analysis]
6 Li X, Li H, Xu Z, Ma C, Wang T, You W, Yu Z, Shen H, Chen G. Ischemia-induced cleavage of OPA1 at S1 site aggravates mitochondrial fragmentation and reperfusion injury in neurons. Cell Death Dis 2022;13:321. [PMID: 35395832 DOI: 10.1038/s41419-022-04782-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Boehm MA, Bonaventura J, Gomez JL, Solís O, Stein EA, Bradberry CW, Michaelides M. Translational PET applications for brain circuit mapping with transgenic neuromodulation tools. Pharmacol Biochem Behav 2021;204:173147. [PMID: 33549570 DOI: 10.1016/j.pbb.2021.173147] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Desloovere J, Boon P, Larsen LE, Goossens MG, Delbeke J, Carrette E, Wadman W, Vonck K, Raedt R. Chemogenetic Seizure Control with Clozapine and the Novel Ligand JHU37160 Outperforms the Effects of Levetiracetam in the Intrahippocampal Kainic Acid Mouse Model. Neurotherapeutics 2021. [PMID: 34862591 DOI: 10.1007/s13311-021-01160-0] [Reference Citation Analysis]
9 Kolesov DV, Sokolinskaya EL, Lukyanov KA, Bogdanov AM. Molecular Tools for Targeted Control of Nerve Cell Electrical Activity. Part II. Acta Naturae 2021;13:17-32. [PMID: 35127143 DOI: 10.32607/actanaturae.11415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Doyle BM, Singer ML, Fleury-Curado T, Rana S, Benevides ES, Byrne BJ, Polotsky VY, Fuller DD. Gene delivery to the hypoglossal motor system: preclinical studies and translational potential. Gene Ther 2021. [PMID: 33574581 DOI: 10.1038/s41434-021-00225-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]